http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28983fea8a1ccf04002e1e002a73624d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Radford |
| name | John A. Radford John A Radford |
| given-name | John A. John A |
| organization-name | From the University of Southampton, Medical Research Council (MRC) Clinical Trials Unit, London; Weston Park Hospital, Sheffield; Queen Elizabeth Hospital, Birmingham; The Christie National Health Services Foundation Trust; and The University of Manchester, Manchester, United Kingdom. Cancer Research UK Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; School of Cancer and Imaging Sciences, The University of Manchester, Manchester, UK School of Cancer Imaging Sciences, Faculty of Medical and Human Sciences, The University of Manchester, Manchester; From the ICRF Medical Oncology Unit and Department of Histopathology, St. Bartholomew's Hospital, London, Department of Hematology, Taunton and Somerset Hospital, Taunton, CRC Department of Medical Oncology, Christie Hospital, Manchester, and Schering Health Care Limited, Burgess Hill, West Sussex, England; Department of Hematology, Centre Hospitalier Lyon Sud, Lyon, France; Divisione di Ematologia, Ospedali Riuniti, Bergamo, Italy; and Department of Hematology, Georg-August Universität, Göttingen, Germany. Anthony J. Swerdlow, Rosie Cooke, and Alan Horwich, Institute of Cancer Research; David Cunningham, Royal Marsden Hospital, Sutton; Andrew Bates, Southampton General Hospital, Southampton; Stephen J. Falk, Bristol Haematology and Oncology Centre, Bristol; Dianne Gilson, St James Institute of Oncology, Leeds; Barry W. Hancock, Weston Park Hospital, Sheffield; Sarah J. Harris, Guy's and St Thomas'; David C. Linch, University College Hospital; T. Andrew Lister, St Bartholomew's Hospital, London; Peter J.... Cancer Research United Kingdom Department of Medical Oncology, The University of Manchester and Christie Hospital NHS Trust, Manchester, United Kingdom Andrew R. Pettitt, Richard Jackson, Stacey Carruthers, James Dodd, Susanna Dodd, and Melanie Oates, University of Liverpool; Andrew R. Pettitt and Gillian G Johnson, Royal Liverpool & Broadgreen University Hospitals National Health Service (NHS) Trust, Liverpool; Anna Schuh, Oxford Radcliffe Hospitals NHS Trust, Oxford; Estella Matutes, Claire E. Dearden, and Daniel Catovsky, Institute of Cancer Research and Royal Marsden Hospital NHS Trust, Surrey; John A. Radford and Adrian Bloor, The University of... From the University of Nebraska Medical CenterOmaha, NE; University of Michigan Medical Center, Ann Arbor, MI; University of Alabama-Birmingham, Birmingham, AL; St Bartholomew’s Hospital, London; Christie Hospital National Health Service Trust, Manchester, England; Stanford University Medical Center, Palo Alto; Coulter Pharmaceutical, South San Francisco, CA; and Memorial Sloan-Kettering Cancer Center, New York, NY. 8The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom. From the University of Michigan Medical Center, Ann Arbor, MI; Christie Hospital, Manchester, UK; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; The New York Hospital-Cornell Medical Center, New York, NY; Stanford University Medical Center, Stanford, CA; Corixa Corporation, Seattle, WA; and Johns Hopkins School of Medicine, Baltimore, MD Tim M. Illidge, Sam Mayes, John A. Radford, W. David J. Ryder, Manchester Academic Health Science Centre, University of Manchester; Jill Tipping, Maureen Zivanovic, Christie Hospital NHS Foundation Trust, Manchester; Ruth Pettengell, St. George's, University of London, London; Andrew T. Bates, Southampton University Hospitals NHS Foundation Trust, Southampton; Mike Bayne, Poole Hospital NHS Foundation Trust, Dorset, United Kingdom; Steven Le Gouill, Centre Hospitalier Universitaire Nantes; Françoise... Manchester Academic Health Science Centre University of Manchester and the Christie NHS Foundation Trust Manchester UK Cancer Research UK Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom 1Cancer Research UK and Manchester Academic Health Sciences Centre University of Manchester Christie NHS Foundation Trust Manchester UK Anthony J. Swerdlow, Craig D. Higgins, and Alan Horwich, Institute of Cancer Research; David Cunningham, Royal Marsden Hospital, Sutton; Paul Smith and David C. Linch, University College Hospital; T. Andrew Lister and Ama Z.S. Rohatiner, St Bartholomew's Hospital, London; Barry W. Hancock, Weston Park Hospital, Sheffield; Peter J. Hoskin, Mount Vernon Hospital, Middlesex; and John A. Radford, Christie Hospital and University of Manchester, Manchester, United Kingdom. From the Cancer Research UK Medical Oncology Unit, St Bartholomew's Hospital; Cancer Research UK Translational Oncology Laboratory, Barts and The London, Queen Mary's Medical School, London; Cancer Research UK Clinical Centre, Southampton General Hospital, Southampton; Cancer Research UK Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom; and Millennium Pharmaceuticals Inc, Cambridge, MA. Department of Medical Oncology Christie Hospital Manchester UK From the Imperial Cancer Research Fund Medical Oncology UnitSt Bartholomew’s Hospital, London; Department of Medicine, Royal Marsden Hospital, Sutton; Imperial Cancer Research Fund Cancer Medicine Unit, St. James’ University Hospital, Leeds; Cancer Research Campaign Department of Medical Oncology, Christie Hospital, Manchester; and Department of Clinical Oncology, Nottingham City Hospital, Nottingham, United Kingdom; Centre Jean Bernard, Le Mans; Department of Hematology, Centre Hospitalier Lyon Sud,... |
Incoming Links
Total number of triples: 59.